Viz RV/LV vs PMcardio
AI Verdict
Choose Viz RV/LV if…
Choose Viz RV/LV if your primary concern is the rapid risk stratification of patients with suspected pulmonary embolism (PE) based on CTPA scans. This tool excels at automating right and left ventricular diameter measurements to provide a crucial RV/LV ratio, facilitating quick identification of right heart strain which is a key indicator of PE severity. It's ideal for emergency medicine and radiology departments needing to expedite critical decision-making and enhance care coordination for PE patients.
View Viz RV/LV →Choose PMcardio if…
Choose PMcardio if you require immediate and accurate interpretation of ECGs for a broad spectrum of over 50 cardiac conditions at the point of care. This AI platform is particularly well-suited for emergency physicians, general practitioners, and paramedics who need expert-level ECG analysis to confidently diagnose conditions like STEMI, arrhythmias, and reduced LVEF, even in pre-hospital settings or when specialized cardiology expertise may not be immediately available.
View PMcardio →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
PMcardioPMcardio offers a mobile app and web platform, making it accessible on various devices. It also provides a freemium model with 5 free ECG analyses per month, allowing users to try the platform before committing to a paid plan. Viz RV/LV is cloud-based, but its pricing and accessibility for individual users are not publicly available, suggesting a more enterprise-focused deployment.
Clinical Value
PMcardioPMcardio is CE-certified and clinically validated in over 25 studies, detecting over 50 cardiac conditions, including STEMI/OMI and reduced LVEF, with high accuracy. Viz RV/LV is FDA-cleared and focuses on automating RV/LV ratio measurements from CTPA scans for pulmonary embolism risk stratification. While valuable, PMcardio's broader diagnostic scope and extensive validation studies suggest a wider clinical utility.
Pricing & Value
PMcardioPMcardio offers a transparent freemium model, providing 5 free ECG analyses per month and clear pricing for individual, team, and organizational plans. Viz RV/LV's pricing is not publicly available, which makes it difficult to assess its value proposition, especially for smaller practices or individual clinicians.
Enterprise Readiness
PMcardioBoth tools demonstrate enterprise readiness with HIPAA compliance and BAA availability. PMcardio, however, explicitly highlights enterprise integrations with EHR/CVIS and EMS systems, central report management, and configurable user permissions, indicating a more comprehensive suite of features for large-scale deployments. Viz.ai also serves over 1,400 hospitals and health systems, but specific enterprise features for Viz RV/LV are less detailed in the provided information.
Innovation
TieBoth tools showcase innovation in their respective domains. Viz RV/LV offers automated RV/LV ratio measurement from CTPA scans, a crucial advancement for pulmonary embolism risk stratification. PMcardio introduces 'ECGxplainu2122' for visual AI explainability with heatmaps, enhancing trust and understanding of AI diagnoses, and also offers detection of 50+ cardiac conditions from ECGs. Given the distinct yet impactful innovations in different diagnostic areas, neither can be definitively declared a sole winner in this dimension.
Support & Docs
PMcardioPMcardio provides a Help Center with user-friendly tutorials and manuals, and its website includes sections for regulatory information and security. While Viz.ai offers customer resources and a 'Viz Academy', the specific details about the depth and accessibility of their documentation and support for Viz RV/LV are less explicit in the provided information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Viz RV/LV | PMcardio |
|---|---|---|
| Company | Viz.ai | Powerful Medical |
| Tagline | AI-powered disease detection and intelligent care coordination | AI that reads ECGs in seconds |
| Regulatory Clearance | FDA-cleared (510(k) clearance for automated RV/LV ratio algorithm) | CE-certified (Class IIb under EU MDR) |
| Primary Modality | CTPA scans | ECGs |
| Key Functionality | Automated Right Ventricle (RV) to Left Ventricle (LV) ratio measurement for pulmonary embolism risk stratification | Interprets ECGs to assess over 50 cardiac conditions, including STEMI/OMI and reduced LVEF |
| Specialties | Emergency Medicine, Pulmonology, Radiology | Cardiology, Emergency Medicine, Internal Medicine |
| Clinical Validation | Clinically validated (part of the Viz PE Solution, which is clinically validated) | Clinically validated in more than 25 studies |
Videos
Demos, reviews, and walkthroughs featuring Viz RV/LV and PMcardio.
Frequently Asked Questions
More Comparisons
More matchups featuring Viz RV/LV or PMcardio
Backers
Who funded each tool's parent company.